Technical Considerations and Protocol Optimization for Neonatal Salivary Biomarker Discovery and Analysis.
Elizabeth Yen1,2, Tomoko Kaneko-Tarui1, Jill L Maron1,2
1Mother Infant Research Institute at Tufts Medical Center, Boston, MA, United States.
Frontiers in Pediatrics
|February 12, 2021
Summary
Saliva analysis offers a non-invasive method for monitoring premature infants. Optimizing collection and analysis techniques is crucial for reliable neonatal biomarker discovery and improved clinical care.
Area of Science:
- Neonatal Medicine
- Biomarker Discovery
- Molecular Diagnostics
Background:
- Non-invasive monitoring of neonates, especially premature infants, is a significant goal in newborn medicine.
- Advances in high-throughput, multiplexed transcriptomic and proteomic platforms enable detailed physiological and pathological analysis.
- Saliva is an advantageous biofluid for serial assessment in neonates due to its non-invasive nature and suitability for advanced analyses, despite challenges like biomarker degradation and mixed human/microbial content.
Purpose of the Study:
- To provide insights into technical considerations and protocol optimizations for quantifying and discovering neonatal salivary biomarkers.
- To improve the reproducibility and reliability of salivary biomarker analyses in the neonatal population.
- To highlight the importance of standardized approaches for successful implementation in neonatal care.
Main Methods:
- Development and refinement of laboratory protocols for neonatal saliva collection, processing, and downstream analyses.
- Application of multiplexed transcriptomic and proteomic platforms for high-throughput biomarker analysis.
- Evaluation of technical considerations including sample handling and assay sensitivity for limited sample volumes.
Main Results:
- Identification of key technical considerations and protocol optimizations for neonatal salivary biomarker analysis.
- Demonstration of saliva's potential as a valuable biofluid for neonatal monitoring using advanced analytical platforms.
- Highlighting the challenges associated with biomarker degradation and the mixed nature of saliva.
Conclusions:
- Optimized protocols are essential for reliable and reproducible neonatal salivary biomarker discovery.
- Standardized approaches and a comprehensive understanding of saliva's benefits and limitations are needed.
- Robust research is required to translate these findings into impactful neonatal clinical care.
More Related Videos
08:50Multiplexed Fluorescent Microarray for Human Salivary Protein Analysis Using Polymer Microspheres and Fiber-optic Bundles
Published on: October 10, 2013
11.9K
08:25Collecting Saliva and Measuring Salivary Cortisol and Alpha-amylase in Frail Community Residing Older Adults via Family Caregivers
Published on: December 18, 2013
11.7K
